Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1Phase 4 1Phase 2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 1Dermatologic 1

Conditions

Uveitis 1Uveal Melanoma 1Retinoblastoma 1Retinal Neoplasms 1Eye Neoplasms 1Choroid Neoplasms 1

Interventions

Cisplatin 725Carboplatin 607Paclitaxel 578Cyclophosphamide 516Radiotherapy 511Docetaxel 475Fluorouracil 453Gemcitabine 437Doxorubicin 383Capecitabine 361Dexamethasone 327Oxaliplatin 288pembrolizumab 283Leucovorin 282Bevacizumab 275Etoposide 271Vincristine 270Rituximab 246Prednisone 222Pemetrexed 217Cytarabine 205Drug Therapy 194Trastuzumab 175Irinotecan 172Methotrexate 171Lenalidomide 137Nivolumab 135Filgrastim 135Epirubicin 129Tamoxifen 127

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Interventional × Eye Enucleation × Clear all
NCT00186888 2025-09-04

Study of Treatment for Patients With Cancer of the Eye -Retinoblastoma

St. Jude Children's Research Hospital

Phase 3 Completed
107 enrolled 34 charts
Other solid neoplasm

Eye Neoplasms, Retinoblastoma, Retinal Neoplasms

NCT00000124 2006-06-02

Collaborative Ocular Melanoma Study (COMS)

National Eye Institute (NEI)

Phase 3 Unknown
Dermatologic

Uveal Melanoma, Choroid Neoplasms, Uveitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡